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ACKGROUND: A population of circulating 
Endothelial Progenitor Cells (EPCs) has been 
reported to play important role in maintaining 
endothelial function and integrity. Since EPCs culture is 
crucial and an optimized medium is currently available. 
Therefore we conducted a study to investigate whether 
stable angina subjects peripheral blood-derived EPCs could 
be cultured in this medium. Here, we performed study 
to detect EPCs characteristics and extracellular signal-
regulated kinase (Erk)1/2 Mitogen-Activated Protein 
Kinase (MAPK) pathway as possible underlying pathway 
for EPCs proliferation.
METHODS: Peripheral blood EPCs from 8 stable angina 
subjects were cultured in an optimized medium with/without 
addition of supplement for 1 or 3 days. Then, the membrane 
of cultured EPCs were detected with immunoluorescence 
method for CD34, Vascular Endothelial Growth Factor 
Receptor 2 (VEGFR-2) and CD133. Colony forming unit 
(CFU) enumeration was performed. XTT Cell proliferation 
assay was performed to assess EPCs growth after 1 and 
3-days culture. The western blot analysis was performed to 
detect possible activation of Erk1/2 MAPK.
RESULTS: Number of EPCs and CFU cultured for 3 days 
were signiicantly higher than the ones cultured for 1 day 
L
ATAR BELAKANG: Populasi Sel Progenitor 
Endotel / Endothelial Progenitor Cells (EPCs) 
yang bersirkulasi telah dilaporkan berperan penting 
dalam memelihara fungsi dan integritas endotel. Oleh karena 
kultur EPCs sangat penting dan medium yang teroptimasi 
telah tersedia, maka kami melakukan suatu penelitian untuk 
mengetahui apakah medium tersebut dapat digunakan 
sebagai medium kultur EPCs yang berasal dari darah tepi 
subyek angina pektoris. Kami melakukan penelitian untuk 
menguji karakteristik EPCs dan jalur extracellular signal-
regulated kinase (Erk)1/2 Mitogen-Activated Protein Kinase 
(MAPK) yang kemungkinan merupakan jalur mekanisme 
proliferasi EPCs.
METODE: EPCs darah tepi dari subyek angina pektoris 
dikultur dalam medium teroptimasi dengan diberikan atau 
tidak diberikan tambahan suplemen, selama 1 atau 3 hari. 
Kemudian membran EPCs hasil kultur dideteksi dengan 
metode imunoluoresens untuk mendeteksi CD34, Vascular 
Endothelial Growth Factor Receptor 2 (VEGFR-2) dan 
CD133. Enumerasi colony forming unit (CFU) dilakukan. 
Uji proliferasi sel XTT dilakukan untuk mengukur 
pertumbuhan EPCs pada kultur 1 dan 3 hari. Analisa 
western blot dilakukan untuk mendeteksi kemungkinan 
adanya aktivasi Erk1/2 MAPK.
Abstract Abstrak
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Cardiovascular disease (CVD) is the main cause of 
mortality in developed and developing countries.(1) 
Multiple cardiovascular risk factors cause endothelial injury 
and endothelial dysfunction leading to vasoconstriction, 
thrombosis, iniltration of monocytic cells, smooth muscle 
cell proliferation, and formation of atherosclerosis.(2,3) 
Maintenance of endothelial integrity and function are 
important to preserve a healthy vasculature.(4) Indeed, the 
balance between endothelial injury and endothelial recovery 
is paramount to reduce cardiovascular events.(5)
 Many studies have identiied a population of 
circulating Endothelial Progenitor Cells (EPCs) integrating 
into sites of neovascularization and endothelial impairment.
(2) Circulating EPCs  are mobilized immature cells from 
bone marrow into the bloodstream, in response to particular 
growth factors and cytokines. EPCs may contribute in 
vascular repair after differentiate into endothelial cell.(6)
 Clinical studies showed that risk factors of 
atherosclerosis are related to the reduced levels of circulating 
EPCs.(2,7) The functional integrity of the endothelium is 
also comparable to the activities of EPCs.(2) The amount of 
circulating EPCs correlates negatively with the established 
risk.(8) Decreased level of circulating EPCs has become an 
independent predictors of atherosclerotic disease progression 
and measurement of EPCs has become a predictive value for 
cardiovascular outcomes in stable coronary artery disease 
patients.(4,9) The reduced circulating EPCs can relect the 
(p=0.012). EPCs membrane markers from stable angina 
subjects were detected as well as CFUs were formed. There 
were signiicant increase of EPCs number, CFUs number 
and phosphorylated-Erk2 amount when the groups with and 
without supplement were compared (p<0.05). Meanwhile 
U0126, a MAPK Erk1/2 (MEK1/2) inhibitor, signiicantly 
inhibited the supplement-induced EPCs number, CFUs 
number and phosphorylated-Erk2 amount (p<0.05).
CONCLUSION: Our results showed that ERK2 MAPK 
signaling pathway might play an important role in 
supplement-induced peripheral blood EPCs proliferation in 
subjects with stable angina.
KEYWORDS: endothelial progenitor cell, EPC, p42, Erk2, 
proliferation
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HASIL: Jumlah EPCs dan CFU meningkat secara 
bermakna setelah dikultur selama 3 hari dibanding dengan 
yang dikultur 1 hari (p=0,012). Marker membran EPCs 
dari subyek angina stabil terdeteksi dan CFUs terbentuk. 
Terdapat peningkatan bermakna dari jumlah EPCs, jumlah 
CFUs dan jumlah Erk2 yang terfosforilasi ketika grup 
yang diberikan dan tidak diberikan suplemen dibandingkan 
(p<0,05). Sedangkan ketika diberikan U0126, inhibitor 
MAPK Erk1/2 (MEK1/2), jumlah EPCs, jumlah CFUs dan 
jumlah Erk2 yang terfosforilasi secara bermakna berkurang 
(p<0,05).
KESIMPULAN: Hasil kami memperlihatkan jalur 
pensinyalan ERK2 MAPK berperan penting pada proliferasi 
EPCs yang berasal dari darah tepi subyek angina stabil. 
KATA KUNCI: sel progenitor endotel, EPC, p42, Erk2, 
proliferasi
Introduction
potential cardiovascular morbidity and mortality.(10-12) A 
long-term study shows that assessment of subpopulations 
of circulating EPCs in patients with stable angina treated 
with percutaneous coronary intervention can improve 
characterization of long-term prognosis, suggesting the 
possibility of using EPCs as biomarkers for the prediction 
of cardiovascular outcome.(13)
 In regards to mechanisms and underlying signaling 
pathways, spleen-derived EPCs proliferation was shown to 
be regulated by the phosphatidylinositol-3-kinase (PI3K)/
Akt/nuclear factor kappa B (NFκB)/survivin signaling 
pathway.(14) Meanwhile, in liver regeneration, Notch 
signaling differentially regulated bone marrow-derived two 
types of EPCs, early EPCs and endothelial outgrowth cells.
(15) Transforming Growth Factor beta 1 (TGF-β1) was 
reported to play a role in the growth and differentiation of 
EPCs. Involvement of extracellular signal-regulated kinase 
(Erk)1/2 Mitogen-Activated Protein Kinase (MAPK) 
signaling pathway was shown in Granulocyte-Macrophage 
Colony-Stimulating Factor (GM-CSF)-induced peripheral 
blood-derived EPCs culture.(16) Since EPCs culture is 
crucial, and an optimized mediums is currently available. This 
medium could be potential to accelerate EPCs proliferation. 
However, by using this medium, characteristics, proliferation 
and signaling pathway of cultured-EPCs derived from 
different sources, are not disclosed yet. In our current study, 
stable angina subjects peripheral blood-derived EPCs were 
cultured in an established culture medium, and then the 
EPCs characteristics and Erk1/2 MAPK activation were 
investigated.
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better cell determination, 4',6-diamidino-2-phenylindole 
(DAPI) staining was performed. Cell expression was 
documented under a luorescence microscope.
Cell Proliferation Assay
Na,3’-[(phenylamino)-carbonyl]-3,4-tetrazolium]-bis(4-
methoxy-6-nitro)benzenesulfonic acid hydrate (XTT) Cell 
Proliferation Assay Kit (Cayman Chemical Company, 
Ann Arbor, MI) was used for cell proliferation assay. The 
assay is based on the extracellular reduction of XTT by 
nicotinamide adenine dinucleotide (NADH) produced 
in the mitochondria via transplasma membrane electron 
transport and an electron mediator.  Briely, XTT mixture 
was added into each well and incubated in a 37°C 5% CO2 
incubator for 4 hours. The absorbance was measured using a 
microplate reader at a wavelength of 450 nm. To interpolate 
cell number, some wells containing cells were trypsinized 
and stained with trypan blue. The cell was then counted 
using hemocytometer under an inverted light microscope.
Western Blot
Cells were harvested and incubated with lysis buffer 
containing 25 mM Tris HCl buffer (pH 7.6), 150 mM 
NaCl, 1% Triton-X, 0.1% sodium dodecyl sulfate (SDS), 
Protease Inhibitor Cocktail [containing 4-(2-aminoethyl)
benzenesulfonyl luoride hydrochloride, aprotinin, bestatin 
hydrochloride, N-(trans-Epoxysuccinyl)-L-leucine 4-guani-
dinobutylamide, leupeptin, pepstatin A) (Sigma-Aldrich, 
St.Louis, MO)], Phosphatase Inhibitor Cocktail 3 [containing 
cantharidin, (-)-p-bromolevamisole oxalate, calyculin A 
(Sigma-Aldrich)]. Samples were separated by 10% SDS-
polyacrylamide gel electrophoresis and transferred to a 
polyvinylidene diluoride membrane (Bio-Rad Laboratories, 
Inc., Hercules, CA).  After blocking with 5% skim milk in 
PBS, the membrane was probed with 1:1000 diluted rabbit 
polyclonal anti-phospho-Erk1/2 MAPK (Thr202/Tyr204) 
antibody (Cell Signaling Technology, Inc., Danvers, MA). 
The secondary antibody was 1:2000 diluted goat anti-rabbit 
IgG horseradish peroxidase-linked antibody (Cell Signaling 
Technology, Inc.). The bound antibodies were visualized 
using Immun Star HRP Chemiluminescent Kit (Bio-Rad 
Laboratories, Inc.). Membrane was then stripped with 
Seppro stripping buffer (Sigma-Aldrich), blocked with 5% 
skim milk in PBS, probed with rabbit polyclonal anti-Erk1/2 
MAPK (Cell Signaling Technology, Inc.), bound with same 
secondary antibody and visualized with chemiluminescent 
kit. All visualized bands were captured using Alliance 
4.7 (UVItech, Ltd., Cambridge, UK) and quantiied using 
UVIband software (UVItech, Ltd.).
Methods
Sample Collection and Mononuclear cells (MNCs) 
Isolation
Upon signing informed consent, peripheral blood was 
collected from 8 volunteers with inclusion criteria are as 
follows: stable angina pectoris, males, 50-55 years old, 
coronary angiogram showing >50% stenotic lesions. 
Subjects with history of coronary stent, acute myocardial 
infarction, diabetes mellitus, smoking, critical limb 
ischemia, or coronary artery bypass graft surgery were 
excluded from this study. This protocol was approved by 
The Ethical Committee Medical Research Medical Faculty 
Brawijaya Unversity (No.273/EC/KEPK-S3/06/2013) 
and The Ethical Committee / Institutional Review Board 
of National Cardiac Center Harapan Kita Hospital (No.
LB.05.01.1.4/55/2013). MNCs was isolated using 
Lymphoprep (Stemcell Technologies, Vancouver, Canada). 
Briely, collected peripheral blood was immediately diluted 
with equal amount of phosphate buffer saline (PBS) plus 
2% fetal bovine serum (FBS), then layered on top of 
Lymphoprep. With centrifugation at 800x g for 20 minutes, 
MNCs layer was formed and collected.
EPCs Culture
Colony Forming Unit (CFU)-Hill Liquid Medium Kit 
(Stemcell Technologies) was used for EPCs culture. Briely, 
after rinsed in PBS plus 2% FBS, MNCs were suspended 
in CFU-Hill Liquid Medium. In each well of 6-well plate, 
5x106 cells of MNCs suspension was plated and incubated 
for 2 days in humidiied 37°C 5% CO2 incubator. Then, 
non-adherent cells were harvested and further cultured for 
3 days to allow formation of CFU-Hill colonies. CFU-Hill 
colonies were enumerated according to kit insert.
Immunoluorescence
After rinsed with PBS, cells were ixed with 4% 
paraformaldehyde. Fixed cells were then treated with 100 
mM glycine and 0.2% Triton X-100 for permeabilization. 
To block nonspeciic binding, 0.1% bovine serum albumin 
in PBS was applied. For antibodies probing, a combination 
of 1:400 diluted mouse monoclonal Alexa Fluor 488 
anti-human CD34, 1:200 diluted mouse monoclonal 
R-phycoerythrin-conjugated anti-CD309 (VEGFR-2/KDR) 
and 1:180 diluted rabbit polyclonal anti-CD133antibodies, 
was applied. Then 1:1000 diluted Alexa Fluor 350 F(ab”)2 
fragment of goat anti-rabbit IgG (H+L) was applied as a 
secondary antibody for the anti-CD133 antibody. To have 
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Results
Peripheral blood-derived EPCs Membrane Marker 
Expression
EPCs membrane markers of CD34 (Figure 1A), VEGFR2 
(Figure 1B) and CD133 (Figure 1C) were expressed under 
a luorescent microscope. EPCs with CD34+, VEGFR2+ 
and CD133+ expressions were merged (Figure 1D). 
The captured EPCs were shown as a CFU under a light 
microscope (Figure 1E).
Increased number of EPCs and CFU
Number of EPCs and CFU cultured for 3 days were 
signiicantly higher than the ones cultured for 1 day 
Statistical Analysis
Analyses were performed using IBM SPSS for Windows 
version 19.0 (IBM Corp., Armonk, NY).  Wilcoxon Signed 
Rank Test was used to determine the statistical differences. 
A probability value <0.05 was considered to be statistically 
signiicant.
Figure 1. Expression of EPCs membrane markers and 
CFU. Collected MNCs were cultured and characterized with 
immunoluorescenceas described in Methods. EPCs membrane 
markers of CD34 (A), VEGFR2 (B) and CD133 (C) were 
documented. In addition, DAPI-stained EPCs were also visualized 
(C) under an inverted luorescence microscope. D: Merge of A, B 
& C. E:  CFU-Hill colony was documented under an inverted light 
microscope. White bar: 50 μm. Black bar: 100 μm.
Figure 2. Supplement induced EPCs proliferation and CFU 
formation.
After collected MNCs were incubated for 2 days as described in 
Methods, the non-adherent cells were harvested and cultured for 1 
or 3 days with supplement of medium kit. For EPCs proliferation, 
XTT assay was performed as described in Methods. Meanwhile, 
CFU was enumerated under a standard light microscope. Data 
were analyzed with Wilcoxon Signed Rank Test, *p<0.05.
(p=0.012) (Figure 2). Number of EPCs was increased 
signiicantly at 1.94-fold (p=0.012). In the same comparison 
between culture of 3 days and 1 day, number of CFU was 
increased signiicantly at 2.36-fold (p=0.012).
Erk2 MAPK activation in EPCs derived from stable 
angina subjects
Expressions of Erk1/2 MAPK were observed in EPCs 
derived from stable angina subjects treated with/without 
supplement, a part of CFU-Hill Liquid Medium Kit, and/or 
U0126, a MAPK Erk1/2 (MEK1/2) inhibitor, for 1 or 3 days 
(Figure 3). Meanwhile phosphorylated-Erk2 expression of 
stable angina subjects was slightly observed only in EPCs 
treated with supplement for 3 days. Number of viable 
EPCs was signiicantly increased for the group treated with 
supplement than without supplement in both durations of 1 
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There is an increasing interest in EPCs due to their 
contribution in the maintenance of endothelial integrity.(5) 
At irst, the description of EPCs isolation from peripheral 
blood was introduced by Asahara et al.(17) Then later on, 
the evolving process of EPCs into mature and functional 
endothelial cells was reported.(8,18) In this current study, 
we aim to analyze the cultured-EPCs derived from stable 
angina subjects in an established commercially available 
medium. Peripheral blood-derived EPCs were generated 
and conirmed by verifying EPCs membrane marker CD34, 
CD133 and VEGFR2. In addition, CFUs were also resulted. 
We found that the number of EPCs and CFUs signiicantly 
increased upon addition of supplement provided along with 
medium (p=0.012).  When we cultured EPCs in a longer 
duration for 3 days, higher numbers of EPCs and CFUs 
were observed. 
 MAPK  pathway relies, ampliies and integrates 
signals from any enermous array of stimuli and establish 
Discussion
some physiological responses, such as: cellular proliferation, 
differentiation, development, transformation, inlammatory 
response and apoptosis.(19,20) Moreover, it regulates gene 
expression, metabolism, cell division, morphology, and 
survival as well as proteins phosphorylation.(20) There are 
3 common subfamilies of MAPK: Erk, Jun kinase (Jnk) 
and p38 MAPK in which Erk MAPK has been the most 
extensively studied subfamily by far.(19,21) Mitogenic 
stimulation by some particular growth factors may cause 
activation of the classical Erk family (ERK1/p44 or ERK2/
p42 MAPK).(19,21-23) It has been hypothesized  that the 
activation of  MAPK at G1 seems to be related with its ability 
to enter S phase.(19)  Since involvement of Erk1/2 MAPK 
Figure 3.  Supplement induced phosphorylation of Erk2.
After collected MNCs were incubated for 2 days as described in 
Methods, the non-adherent cells were harvested and cultured for 
1 or 3 days with/without U0126 and supplement of medium kit. 
Then cells were collected, lysed and subjected to western blot to 
detect Erk1/2 and phosphorylated Erk1/2 as described in Methods. 
p-Erk2: phosphorylated Erk2.
day (p=0.012) and 3 days (p=0.012) (Figure 4A). Number of 
CFUs was also signiicantly increased for the group treated 
with supplement than without supplement in both durations 
of 1 day (p=0.012) and 3 days (p=0.012) (Figure 4B). 
Meanwhile, number of EPCs was signiicantly decreased 
for the group trreased for the group treated with U0126 prior 
to supplement, compared to the one treated with supplement 
merely, in both durations of 1 day (p=0.012) and 3 days 
(p=0.012) (Figure 4B).
Figure 4.  U0126 inhibited EPCs proliferation and CFU 
formation.
After collected MNCs were incubated for 2 days as described in 
Methods, the non-adherent cells were harvested and cultured for 
1 or 3 days with/without U0126 and supplement of medium kit. 
For EPCs proliferation, XTT assay was performed as described 
in Methods. Meanwhile, CFU was enumerated under a standard 
light microscope. Data were analyzed with Wilcoxon Signed Rank 
Test, *p<0.05.
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Conclusion
Taken together, our results showed that an important role of 
p42 MAPK in supplement-induced peripheral blood EPCs 
derived from stable angina subjects. Further investigation 
in component of supplement and other potential activated 
signaling pathway should be carried out to clarify the 
mechanism of EPCs proliferation induction in this medium.
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signaling pathway was reported  in peripheral blood-derived 
EPCs culture (16), we then pursued our study in Erk1/2 
signaling pathway as potential pathway for the supplement 
to induce EPCs proliferation and CFUs formation.
 Our current results showed that under induction of 
supplement, Erk2 MAPK of EPCs derived from stable 
angina subjects were slightly phosphorylated. In contrast, 
by addition of U0126, phosphorylation of Erk2 was totally 
diminished. A long with the Erk2 phosphorylation inhibition, 
EPCs growth and CFU formation were also inhibited by 
U0126, showing that activated pathway was ERK2 MAPK-
dependent.
